497 related articles for article (PubMed ID: 26542804)
1. The Voltage-dependent Anion Channel 1 Mediates Amyloid β Toxicity and Represents a Potential Target for Alzheimer Disease Therapy.
Smilansky A; Dangoor L; Nakdimon I; Ben-Hail D; Mizrachi D; Shoshan-Barmatz V
J Biol Chem; 2015 Dec; 290(52):30670-83. PubMed ID: 26542804
[TBL] [Abstract][Full Text] [Related]
2. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
[TBL] [Abstract][Full Text] [Related]
3. VDAC1, mitochondrial dysfunction, and Alzheimer's disease.
Shoshan-Barmatz V; Nahon-Crystal E; Shteinfer-Kuzmine A; Gupta R
Pharmacol Res; 2018 May; 131():87-101. PubMed ID: 29551631
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: release of cytochrome c, AIF and Smac/Diablo.
Shoshan-Barmatz V; Keinan N; Abu-Hamad S; Tyomkin D; Aram L
Biochim Biophys Acta; 2010; 1797(6-7):1281-91. PubMed ID: 20214874
[TBL] [Abstract][Full Text] [Related]
5. VDAC1-interacting anion transport inhibitors inhibit VDAC1 oligomerization and apoptosis.
Ben-Hail D; Shoshan-Barmatz V
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1612-23. PubMed ID: 27064145
[TBL] [Abstract][Full Text] [Related]
6. Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?
Reddy PH
Biochim Biophys Acta; 2013 Jan; 1832(1):67-75. PubMed ID: 22995655
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial Voltage-Dependent Anion Channel 1-Hexokinase-II Complex-Targeted Strategy for Melanoma Inhibition Using Designed Multiblock Peptide Amphiphiles.
Zhang F; Angelova A; Garamus VM; Angelov B; Tu S; Kong L; Zhang X; Li N; Zou A
ACS Appl Mater Interfaces; 2021 Aug; 13(30):35281-35293. PubMed ID: 34309373
[TBL] [Abstract][Full Text] [Related]
8. Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease.
Manczak M; Reddy PH
Hum Mol Genet; 2012 Dec; 21(23):5131-46. PubMed ID: 22926141
[TBL] [Abstract][Full Text] [Related]
9. Voltage-dependent anion channel 1-based peptides interact with hexokinase to prevent its anti-apoptotic activity.
Arzoine L; Zilberberg N; Ben-Romano R; Shoshan-Barmatz V
J Biol Chem; 2009 Feb; 284(6):3946-55. PubMed ID: 19049977
[TBL] [Abstract][Full Text] [Related]
10. Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: mapping the site of binding.
Abu-Hamad S; Zaid H; Israelson A; Nahon E; Shoshan-Barmatz V
J Biol Chem; 2008 May; 283(19):13482-90. PubMed ID: 18308720
[TBL] [Abstract][Full Text] [Related]
11. Key regions of VDAC1 functioning in apoptosis induction and regulation by hexokinase.
Shoshan-Barmatz V; Zakar M; Rosenthal K; Abu-Hamad S
Biochim Biophys Acta; 2009 May; 1787(5):421-30. PubMed ID: 19094960
[TBL] [Abstract][Full Text] [Related]
12. Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect against Mitochondrial Dysfunction.
Ben-Hail D; Begas-Shvartz R; Shalev M; Shteinfer-Kuzmine A; Gruzman A; Reina S; De Pinto V; Shoshan-Barmatz V
J Biol Chem; 2016 Nov; 291(48):24986-25003. PubMed ID: 27738100
[TBL] [Abstract][Full Text] [Related]
13. VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia.
Prezma T; Shteinfer A; Admoni L; Raviv Z; Sela I; Levi I; Shoshan-Barmatz V
Cell Death Dis; 2013 Sep; 4(9):e809. PubMed ID: 24052077
[TBL] [Abstract][Full Text] [Related]
14. Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's disease.
Fernandez-Echevarria C; Díaz M; Ferrer I; Canerina-Amaro A; Marin R
Neuroscience; 2014 Oct; 278():354-66. PubMed ID: 25168729
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of the voltage-dependent anion channel 1 (VDAC1) in Alzheimer's disease transgenic mice: an insight into the pathogenic effects of amyloid-β.
Cuadrado-Tejedor M; Vilariño M; Cabodevilla F; Del Río J; Frechilla D; Pérez-Mediavilla A
J Alzheimers Dis; 2011; 23(2):195-206. PubMed ID: 20930307
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of VDAC1 Rescues A
Zhou X; Tang X; Li T; Li D; Gong Z; Zhang X; Li Y; Zhu J; Wang Y; Zhang B
Mediators Inflamm; 2023; 2023():6739691. PubMed ID: 36816741
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of hesperidin against amyloid-β (Aβ) induced neurotoxicity through the voltage dependent anion channel 1 (VDAC1)-mediated mitochondrial apoptotic pathway in PC12 cells.
Wang DM; Li SQ; Zhu XY; Wang Y; Wu WL; Zhang XJ
Neurochem Res; 2013 May; 38(5):1034-44. PubMed ID: 23475456
[TBL] [Abstract][Full Text] [Related]
18. Voltage-dependent anion channel 1-based peptides interact with Bcl-2 to prevent antiapoptotic activity.
Arbel N; Shoshan-Barmatz V
J Biol Chem; 2010 Feb; 285(9):6053-62. PubMed ID: 20037155
[TBL] [Abstract][Full Text] [Related]
19. The VDAC1 N-terminus is essential both for apoptosis and the protective effect of anti-apoptotic proteins.
Abu-Hamad S; Arbel N; Calo D; Arzoine L; Israelson A; Keinan N; Ben-Romano R; Friedman O; Shoshan-Barmatz V
J Cell Sci; 2009 Jun; 122(Pt 11):1906-16. PubMed ID: 19461077
[TBL] [Abstract][Full Text] [Related]
20. Ca(2+)-mediated regulation of VDAC1 expression levels is associated with cell death induction.
Weisthal S; Keinan N; Ben-Hail D; Arif T; Shoshan-Barmatz V
Biochim Biophys Acta; 2014 Oct; 1843(10):2270-81. PubMed ID: 24704533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
